Corvia Medical today announced three-year positive results from its clinical trial of its Corvia Atrial Shunt.

Patients were divided according to the degree of left-to-right shunt into small (<35%), moderate (35 to 50%), and large (>50%) shunt groups. Data obtained in both the VSD and the PDA groups were ...

Elevated venous pressure in right heart failure leads not only to an increase in lymph formation but also to progressive resistance in the neck to the return of lymph to the circulation via the ...

Background/Aims Transjugular intrahepatic portosystemic shunts (TIPSS) are increasingly used for the management of variceal bleeding and diuretic refractory ascites. Complications include cardiac ...

Patients’ specific prepalliation characteristics (eg, non-cardiac comorbidities, medical treatment, etc), procedure-related morbidity, paediatric intensive care unit (PICU) stay and related ...

Recent paper investigates the effects of dexmedetomidine on oxygenation and pulmonary shunt fraction in high-risk pediatric ...

Clinicians typically perform right heart catheterization using the gold-standard direct Fick method to evaluate cardiac output, disease severity, and shunt correction eligibility in patients with ...

Johnson & Johnson (J&J) has announced the completion of its acquisition of V-Wave, a company specialising in the development ...

Usually, blood from the digestive tract will flow through the liver before returning to the heart. In dogs with a liver shunt ...

Johnson & Johnson (NYSE: JNJ) announced today that it completed the previously announced acquisition of V-Wave.

Saturations increased from 71% (52–83%) to 92% (81–100%) (p<0.001). Two patients required early shunts due to inadequate palliation and two died from non-cardiac causes. Sixteen further catheter ...